Position in ACRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$661,323
+$523,445 QoQ
Shares Held
176,353
+285.0% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90.96811508735321.ToString("F0")%
Shared 0.ToString("F0")%
None 9.031884912646793.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. ACRS ranks #209 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in ACRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $661,323 | 176,353 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $137,878 | 45,807 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $76,664 | 40,350 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $627,990 | 442,247 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $701,021 | 458,184 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,138,441 | 459,049 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $627,867 | 545,972 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $758,287 | 689,353 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $833,065 | 671,828 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $704,249 | 670,714 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,529,904 | 661,300 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,757,433 | 748,065 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,092,101 | 753,041 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $12,166,497 | 772,476 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,027,635 | 1,145,339 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $17,342,619 | 1,242,308 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $20,918,154 | 1,213,350 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $21,519,040 | 1,479,989 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,495,602 | 1,583,089 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $29,711,062 | 1,691,974 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $37,824,544 | 1,500,974 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,332,716 | 205,984 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $529,378 | 205,984 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $333,694 | 205,984 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $215,055 | 206,784 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||